Drug intelligence / Profile preview

Xiaoying

Development stage: Preclinical
Lead developer: Shuguang Hospital
Administration: Oral, Topical

Overview

Xiaoying is a Traditional Chinese Medicine (TCM) primarily investigated for the treatment of Hashimoto's Thyroiditis. It is studied in various formulations, such as a mixture for oral administration and a paste for external use, indicating its versatile application within TCM principles. The drug's therapeutic approach is rooted in traditional Chinese medical theory, aiming to address the underlying imbalances associated with the disease.

Other names: Xiaoying MixtureXiaoying Paste消瘿合剂消瘿贴

Targets

NOTCH (Neurogenic locus notch homolog protein 3)

Beyond the preview

Go deeper on Xiaoying.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoying.

Explore the full profile